Does the reported LRCX share ownership include restricted stock units?

Yes. The reported beneficial ownership of 987,237 shares includes shares that are subject to unvested restricted stock units .

LRCX CFO reports 40,080-share sale at $150.6, still holds 987k+

Q: How many LRCX shares did the executive sell and at what price?

The executive sold 40,080 shares of Lam Research common stock at a weighted average sale price of $150.6 per share, with individual trades executed between $150.48 and $150.82 .

Q: How many LRCX shares does the reporting person own after this transaction?

After the reported sale, the executive beneficially owns 987,237 shares of LAM RESEARCH CORP common stock.

Q: What is the role of the insider who filed this LRCX Form 4?

The reporting person is an officer of LAM RESEARCH CORP, serving as Chief Financial Officer & Executive Vice President .

Q: Was this LRCX Form 4 filed for one insider or multiple insiders?

The filing indicates that it is a Form 4 filed by one reporting person , not by a group.

Filing Impact

(Very High)

Filing Sentiment

(Very Negative)

Form Type

Rhea-AI Filing Summary

LAM RESEARCH CORP executive leadership reported an insider share sale. The company’s Chief Financial Officer and Executive Vice President filed a Form 4 disclosing the sale of 40,080 shares of common stock on 11/14/2025. The transaction was coded as a sale and carried a weighted average sale price of $150.6 per share, based on multiple trades within a narrow price range. Following this transaction, the officer reports beneficial ownership of 987,237 shares of Lam Research common stock, which includes shares subject to unvested restricted stock units.

Insider Trade Summary

Net Seller: 40,080 shares

Net Sell 1 txn

Insider Bettinger Douglas R

Role Chief Financial Officer & EVP

Sold 40,080 shs ($6.04M)

Type	Security	Shares	Price	Value
Sale	Common Stock	40,080	$150.60	$6.04M

Holdings After Transaction: Common Stock — 987,237 shares (Direct)

Footnotes (2)

F1. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $150.48 to $150.82 inclusive
F2. The amount reported includes shares subject to unvested restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/17/2025 - 12:58 PM

FAQ

What insider transaction did LAM RESEARCH CORP (LRCX) report in this Form 4?

The Form 4 reports that the Chief Financial Officer and Executive Vice President of LAM RESEARCH CORP (LRCX) sold 40,080 shares of the company’s common stock on 11/14/2025.

How many LRCX shares did the executive sell and at what price?

The executive sold 40,080 shares of Lam Research common stock at a weighted average sale price of $150.6 per share, with individual trades executed between $150.48 and $150.82.

How many LRCX shares does the reporting person own after this transaction?

After the reported sale, the executive beneficially owns 987,237 shares of LAM RESEARCH CORP common stock.

What is the role of the insider who filed this LRCX Form 4?

The reporting person is an officer of LAM RESEARCH CORP, serving as Chief Financial Officer & Executive Vice President.

Was this LRCX Form 4 filed for one insider or multiple insiders?

The filing indicates that it is a Form 4 filed by one reporting person, not by a group.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bettinger Douglas R

(Last)

(First)

(Middle)

4650 CUSHING PARKWAY

(Street)

FREMONT

94538

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
LAM RESEARCH CORP [ LRCX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer & EVP

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/14/2025		S		40,080	D	$150.6⁽¹⁾	987,237⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $150.48 to $150.82 inclusive

2. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	Marta Woods by Power of Attorney	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR